[go: up one dir, main page]

SK284623B6 - Použitie farmaceutickej kombinácie na liečenie závislosti od alkoholu - Google Patents

Použitie farmaceutickej kombinácie na liečenie závislosti od alkoholu Download PDF

Info

Publication number
SK284623B6
SK284623B6 SK1428-2000A SK14282000A SK284623B6 SK 284623 B6 SK284623 B6 SK 284623B6 SK 14282000 A SK14282000 A SK 14282000A SK 284623 B6 SK284623 B6 SK 284623B6
Authority
SK
Slovakia
Prior art keywords
treatment
nmda receptor
modulator
opioid antagonist
alcohol
Prior art date
Application number
SK1428-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK14282000A3 (sk
Inventor
Martine Daoust
Yves Bonhomme
Philippe Durbin
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of SK14282000A3 publication Critical patent/SK14282000A3/sk
Publication of SK284623B6 publication Critical patent/SK284623B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1428-2000A 1998-03-26 1999-03-26 Použitie farmaceutickej kombinácie na liečenie závislosti od alkoholu SK284623B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98400723A EP0945133A1 (en) 1998-03-26 1998-03-26 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
PCT/EP1999/002337 WO1999048500A1 (en) 1998-03-26 1999-03-26 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator

Publications (2)

Publication Number Publication Date
SK14282000A3 SK14282000A3 (sk) 2001-05-10
SK284623B6 true SK284623B6 (sk) 2005-08-04

Family

ID=8235311

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1428-2000A SK284623B6 (sk) 1998-03-26 1999-03-26 Použitie farmaceutickej kombinácie na liečenie závislosti od alkoholu

Country Status (18)

Country Link
US (1) US6512009B1 (hu)
EP (2) EP0945133A1 (hu)
KR (1) KR20010034678A (hu)
AT (1) ATE230993T1 (hu)
AU (1) AU758569B2 (hu)
BR (1) BR9909138A (hu)
CA (1) CA2325739C (hu)
CZ (1) CZ296367B6 (hu)
DE (1) DE69904922T2 (hu)
DK (1) DK1063995T3 (hu)
ES (1) ES2190205T3 (hu)
HK (1) HK1032542A1 (hu)
HU (1) HU226555B1 (hu)
NO (1) NO319313B1 (hu)
PL (1) PL193241B1 (hu)
RU (1) RU2226107C2 (hu)
SK (1) SK284623B6 (hu)
WO (1) WO1999048500A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1243543C (zh) * 1998-07-20 2006-03-01 派普泰克有限公司 生物植入物配方
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
WO2001052851A1 (en) * 2000-01-22 2001-07-26 Albert Shulman Methods for the treatment of substance abuse
EP1262196A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination of a monoamine reuptake inhibitor and an opioid antagonist for use in alcoholism and alcohol dependence
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
ES2187288B1 (es) * 2001-09-24 2004-09-16 Garbil Pharma Investigacion Chile Ltda Aminas como agentes anti-alcoholismo.
AU2003240493B2 (en) * 2002-05-31 2008-06-12 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Implantable polymeric device for sustained release of buprenorphine
CA2779723C (en) 2002-12-13 2014-03-25 Durect Corporation Oral drug delivery system
WO2004056337A2 (en) * 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
DE602004031512D1 (de) * 2003-03-31 2011-04-07 Titan Pharmaceuticals Inc Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten
CA2526101A1 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
MX2009006672A (es) * 2006-12-19 2009-10-26 Univ Virginia Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol.
AU2008335809A1 (en) * 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
JP2011515076A (ja) 2008-02-28 2011-05-19 ユニバーシティ オブ バージニア パテント ファウンデーション セロトニン輸送体遺伝子およびアルコール中毒症の処置
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
SI2801625T1 (en) 2010-07-02 2018-04-30 University Of Virginia Patent Foundation Molecular genetic approach to treatment and diagnosis of alcohol and drug addiction
WO2013036721A1 (en) 2011-09-09 2013-03-14 University Of Virginia Patent Foundation Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
RU2476209C1 (ru) * 2012-02-29 2013-02-27 Станислав Анатольевич Кедик Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
GB201308440D0 (en) * 2013-05-10 2013-06-19 Dalgleish Angus Therapeutic
US20240350433A1 (en) * 2021-08-17 2024-10-24 Yale University Treatment compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
WO1997033581A1 (en) * 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds

Also Published As

Publication number Publication date
EP1063995A1 (en) 2001-01-03
DE69904922T2 (de) 2004-01-08
RU2226107C2 (ru) 2004-03-27
SK14282000A3 (sk) 2001-05-10
HU226555B1 (en) 2009-03-30
WO1999048500A1 (en) 1999-09-30
HK1032542A1 (en) 2001-07-27
BR9909138A (pt) 2000-12-05
NO20004788L (no) 2000-11-24
US6512009B1 (en) 2003-01-28
HUP0101546A3 (en) 2002-10-28
CA2325739A1 (en) 1999-09-30
ATE230993T1 (de) 2003-02-15
PL193241B1 (pl) 2007-01-31
CZ20003525A3 (cs) 2001-04-11
NO20004788D0 (no) 2000-09-25
AU3522699A (en) 1999-10-18
AU758569B2 (en) 2003-03-27
HUP0101546A2 (hu) 2001-09-28
DK1063995T3 (da) 2003-03-10
CZ296367B6 (cs) 2006-02-15
PL343069A1 (en) 2001-07-30
DE69904922D1 (de) 2003-02-20
KR20010034678A (ko) 2001-04-25
ES2190205T3 (es) 2003-07-16
EP0945133A1 (en) 1999-09-29
CA2325739C (en) 2007-05-15
EP1063995B1 (en) 2003-01-15
NO319313B1 (no) 2005-07-11

Similar Documents

Publication Publication Date Title
SK284623B6 (sk) Použitie farmaceutickej kombinácie na liečenie závislosti od alkoholu
US20010053777A1 (en) Drug treatment for restless leg syndrome
MXPA02011610A (es) Combinacion de sustancia activa que contiene un opioide que tiene una estructura tipo fentanilo y cetamina.
EA000976B1 (ru) Композиция для снятия боли и способ снятия боли
CA2450787C (en) Active ingredient combination for pharmacological addictive substance or intoxicant therapy
JP2007509146A (ja) レボドーパの持続効果のための組成物及び投与形
CZ20021116A3 (cs) Synergické kombinace antagonisty receptoru NK1 a strukturálního analogu GABA
AU2016263292A1 (en) Combinations of opioids and N-acylethanolamines
US6026817A (en) Method of treating the syndrome of coronary heart disease risk factors in humans
CA2576385C (en) Novel formulation for l-tryptophane comprising carbidopa/benserazide
US20010034320A1 (en) NK1-receptor antagonists for treating restless legs syndrome
US20100203084A1 (en) Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
GB2163957A (en) Anti-asthma compositions containing ketotifen
CA2409845C (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
MXPA00009257A (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
JP2006522786A (ja) 痙縮及びまたは疼痛治療用薬剤組合わせ
KR20020063180A (ko) 물질 탐닉 치료방법

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140326